BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9723027)

  • 1. 5q- in a child with refractory anemia with excess blasts: similarities to 5q- syndrome in adults.
    Antillón F; Raimondi SC; Fairman J; Liang H; Nagarajan L; Head D; Ribeiro RC
    Cancer Genet Cytogenet; 1998 Sep; 105(2):119-22. PubMed ID: 9723027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of megakaryocytic morphology in diagnosing 5q- syndrome.
    Thiede T; Engquist L; Billström R
    Eur J Haematol; 1988 Nov; 41(5):434-7. PubMed ID: 3208866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
    Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
    Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome following haematopoietic cell transplantation in patients with myelodysplasia and del (5q) karyotypes.
    Stewart B; Verdugo M; Guthrie KA; Appelbaum F; Deeg HJ
    Br J Haematol; 2003 Dec; 123(5):879-85. PubMed ID: 14632779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematological features of patients with myelodysplastic syndromes associated with a chromosome 5q deletion.
    Lewis S; Oscier D; Boultwood J; Ross F; Fitchett M; Rack K; Abrahamson G; Buckle V; Wainscoat JS
    Am J Hematol; 1995 Jul; 49(3):194-200. PubMed ID: 7604812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid disorders with deletion of 5q as the sole karyotypic abnormality: the clinical and pathologic spectrum.
    Washington LT; Doherty D; Glassman A; Martins J; Ibrahim S; Lai R
    Leuk Lymphoma; 2002 Apr; 43(4):761-5. PubMed ID: 12153162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow morphology predicts additional chromosomal abnormalities in patients with myelodysplastic syndrome with del(5q).
    Geyer JT; Verma S; Mathew S; Wang YL; Racchumi J; Espinal-Witter R; Subramaniyam S; Knowles DM; Orazi A
    Hum Pathol; 2013 Mar; 44(3):346-56. PubMed ID: 22995330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukemic transformation in patients with 5Q- and additional abnormalities.
    Larripa I; Acevedo S; Palau Nagore MV; Bengiò R; Mondini N; Slavutsky I
    Haematologica; 1991; 76(5):363-7. PubMed ID: 1806438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of chromosome studies and their relation to morphology, course, and prognosis in 120 patients with de novo myelodysplastic syndrome.
    Suciu S; Kuse R; Weh HJ; Hossfeld DK
    Cancer Genet Cytogenet; 1990 Jan; 44(1):15-26. PubMed ID: 2293879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5q- syndrome in a child.
    Uyttebroeck A; Brock P; De Groote B; Renard M; Dal Cin P; Van den Berghe H; Casteels-Van Daele M
    Cancer Genet Cytogenet; 1995 Apr; 80(2):121-3. PubMed ID: 7736428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Unusual initial manifestation in a case of refractory anemia with excess of blasts].
    Beris P; Soulier-Lauper M; Parlier V; Jotterand-Bellomo M
    Schweiz Med Wochenschr; 1991 Oct; 121(41):1499-502. PubMed ID: 1947947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity of haematological indicators for '5q- syndrome' in patients with myelodysplastic syndromes.
    Teerenhovi L
    Eur J Haematol; 1987 Oct; 39(4):326-30. PubMed ID: 3691757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetic studies in 112 cases of untreated myelodysplastic syndromes.
    Solé F; Prieto F; Badia L; Woessner S; Florensa L; Caballin MR; Coll MD; Besses C; Sans-Sabrafen J
    Cancer Genet Cytogenet; 1992 Nov; 64(1):12-20. PubMed ID: 1458444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unusual findings in two patients with acquired deletions of the long arm of chromosome 5 (5q-).
    Lishner M; Amato D; Chalvardjian P; Baker MA; Fernandes B; Pantalony D; Dube ID
    Clin Lab Haematol; 1991; 13(1):87-92. PubMed ID: 2060266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined immunophenotyping and FISH identifies the involvement of B-cells in 5q- syndrome.
    Jaju RJ; Jones M; Boultwood J; Kelly S; Mason DY; Wainscoat JS; Kearney L
    Genes Chromosomes Cancer; 2000 Nov; 29(3):276-80. PubMed ID: 10992302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical management of myelodysplastic syndromes with interstitial deletion of chromosome 5q.
    Nimer SD
    J Clin Oncol; 2006 Jun; 24(16):2576-82. PubMed ID: 16735711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematologic and cytogenetic remission of 5q-refractory anemia after syngeneic bone marrow transplantation.
    Stuart RK; Mangan KF
    Am J Med; 1986 Mar; 80(3):503-7. PubMed ID: 3082200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trisomy 14 in myelodysplastic syndromes: report of two cases and review of the literature.
    Vasef MA; Murata-Collins JL; Alsabeh R; Medeiros LJ
    Arch Pathol Lab Med; 1998 Jan; 122(1):77-83. PubMed ID: 9448022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The presence of clonal cell subpopulations in peripheral blood and bone marrow of patients with refractory cytopenia with multilineage dysplasia but not in patients with refractory anemia may reflect a multistep pathogenesis of myelodysplasia.
    Cermák J; Belicková M; Krejcová H; Michalová K; Zilovcová S; Zemanová Z; Brezinová J; Sieglová Z
    Leuk Res; 2005 Apr; 29(4):371-9. PubMed ID: 15725470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myelodysplastic syndrome with partial deletion of the long arm of chromosome 5: first report of a case in a child.
    Shikano T; Ishikawa Y; Anakura M
    Acta Paediatr Jpn; 1992 Oct; 34(5):539-42. PubMed ID: 1442027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.